For the first time in six years, the DEA has ordered a suspension on a pharmaceutical wholesaler, and it’s a Big Pharma opioid distributor- Morris & Dickson.
We now know that officials all over the country, both at the state and federal levels, are joining forces to go after Big Pharma companies for pushing powerful opioid painkillers that contributed to one of the greatest addiction outbreaks in American history. While not everyone agrees on the role prescription drugs played in the opioid crisis, many believe the questionable marketing and distribution practices is reason enough for real intervention.
Lawsuits against opioid makers are taking place all over the US, and distribution companies are finding themselves in the hot seat.
DEA vs Opioid Distributor
This latest news comes following an investigation into Morris & Dickson. Allegedly, the investigation uncovered evidence that the Big Pharma opioid distributor neglected to inform the DEA about large quantities of addiction painkillers being bought up by independent pharmacies.
This is a problem because, according to The Hill, reporting such information to the DEA is a requirement.
Back in October of 2017 the investigation into the opioid distributor out of Shreveport, Louisiana got kicked off after reports came in that Morris & Dickson had sold narcotics to five of the state’s top 10 drug-purchasing pharmacies, but never filed any suspicious activity reports in any of these cases. In a statement Friday, the Justice Department revealed that according to the DEA investigation, independent pharmacies were allowed to purchase six times the amount they would normally order from the opioid distributor.
For the record- pharmaceutical distributors like Morris & Dickson are legally required to report unusually large shipments of narcotics to the government as a safeguard against prescription medications from making their way to the illicit drug market. DEA Acting Administrator Robert W. Patterson said in a statement:
“Distributors have an obligation to ensure that all pharmaceutical controlled substances their customer’s order are for legitimate use, and it is their duty to identify, recognize and report suspicious orders to DEA,”
“This is another reminder that DEA will hold accountable those companies who choose to operate outside the law.”
The Big Pharma opioid distributor will have the chance to appeal the suspension during an administrative hearing.
Morrison & Dickson Fight Back
Let the record show that Morrison & Dickson are definitely not taking these charges sitting down. The opioid distributor has struck back against the suspension with a federal lawsuit. They adamantly hold that they will fight the suspension. Company president Paul M. Dickson released his own statement, saying:
“Sadly, in this case, the DEA has gotten it wrong. We would’ve proved that to them had they given us the chance.”
They already asked a judge last Thursday to overturn the DEA suspension. In the legal claim against the DEA order the opioid distributor states:
“Make no mistake—this is a life and death situation. Morris & Dickson services 30-40% of the hospital drug market in Louisiana and Texas alone. If Morris & Dickson cannot ship needed medications to these hospitals, these hospitals may face immediate drug shortages.”
The company president also maintains that the opioid distributor has already greatly reduced its circulation of opioids. Dickson emphasizes that the company provides medications that many patients do desparately need. He also acknowledges the devastation caused by the opioid crisis, saying:
“Everyone in the Morris & Dickson family has been touched by the opioid crisis. That’s why we’ve taken aggressive and effective voluntary measures against any potential opioid diversion from medical use. We have reduced our opioid distribution dramatically. And it’s why we’re so proud of our history of 177 years with no outside enforcement actions against us.”
At this point, only time will tell if the company will have to adhere to the suspension for much longer.
Some people argue that moves like this from the DEA are too aggressive or an over-reach. However, given the circumstances, this seems like a logical response. Looking at the massive shipments of Oxycodone and Hydrocodone, it seems like it shouldn’t be too much to ask they notify the DEA.
What is Next?
Big Pharma executives testified for Congress yesterday, answering questions about their role in the prescription drug problem. The Washington Post reports that this could be a defining moment for the opioid industry. Witnesses for the hearing included high ranking executives from:
- Miami-Luken, INC
- McKesson Corporation
- Cardinal Health
- AmerisourceBergen Corporation
- HD Smith Wholesale Drug Company
During the hearing, Congressman Gregg Harper of Mississippi states:
“We have learned much from the investigation but still have many questions,”
“Why did the distributors repeatedly fail to report suspicious orders of opioids or exercise effective controls against diversion?”
He goes on to explain that the DEA identified opioid distributor companies as a key element to combating the diversion of drugs to the black market. He states that distributors have often claimed that they were too limited to properly address these issues, as they do not understand the whole scope as the DEA does. However, he argues that distributors do have a great deal of data collection, and should be aware of their impact.
According to Congressman Harper, distributors also frequently argue that they are simply providing a service. They do not control the demand, but simply offer the supply based on the prescriptions from physicians. This argument seems a bit of a cop-out, and almost sounds like something a street-level drug dealer would say.
The committee also adds that over the course of 6 years, opioid distributor companies filled the state of West Virginia with over 780 million Hydrocodone and Oxycodone pills, while 1,728 people in West Virginia fatally overdosed on those two painkillers.
In their opening statements, each Big Pharma distributor representative acknowledged the devastation of the epidemic. However, when asked by Chairman Harper if they believed their companies contributed to the opioid epidemic, except for the chairman of the board for Miami-Luken Dr. Robert E. Mastandrea, they all said no.
In fact, Dr. Mastandrea seemed to be the only one consistently willing to admit that Miami-Luken had made mistakes that helped create the opioid crisis.
While it will take time to determine the impact of these testimonies, one thing we can say now is that drug distribution companies are quickly finding themselves on the chopping block when it comes down to the efforts to curb prescription opioids abuse.
For now, a crucial part of fighting the opioid epidemic is going to be providing safe and effective addiction treatment. It may not be easy to put a stop to the spread of addiction, but there are programs that can help you break out of the cycle of drug and alcohol abuse. If you or someone you love is struggling, please call toll-free now. We want to help.
(This content is being used for illustrative purposes only; any person depicted in the content is a model)
Bullying is a concept we are all familiar with. We each experience bullying at some point in life, to one extent or another. Even those who become bullies have often been bullied at some point. Technology and social media have created a whole new breed of cyberbullying, and too many people don’t take bullying very seriously. When you look at bullying statistics, the impact can lead to other real issues, including substance abuse and addiction.
To be a Bully
Firstly, let us look at what it is to be a bully. The title is typically described as the use of superior strength or influence to intimidate, typically to force someone to do what one wants. The site stopbullying.gov defines it as unwanted, aggressive behavior that involves real or perceived power imbalance. This behavior is repeated or has the potential to be repeated over time. It also concludes that both those who are bullied and those who bully often have serious, lasting problems.
Bullying statistics show three categories of behavior:
1. Verbal Bullying
This type of bullying is about the things we say or write. Verbal bullying includes:
- Inappropriate sexual comments
2. Social Bullying
This involves hurting someone’s reputation or relationships. Social bullying includes:
- Leaving someone out on purpose
- Telling other children not to be friends with someone
- Spreading rumors about someone
- Embarrassing someone in public
3. Physical Bullying
Physical Bullying involves hurting a person’s body or possessions. It includes:
- Taking or breaking someone’s things
- Making mean or rude hand gestures
Sadly, the prevalence of bullying often convinces people that it is just a rite of passage. A lot of people don’t take the issue seriously enough. Adults often justify the behavior as a sign of immaturity, without realizing the genuine harm that comes from it.
The Impact of Bullying
Being bullied can lead to many other adversities in life, including physical violence and mental health problems.
Because both behaviors are so common, it is difficult to correlate bullying and substance use. When looking at addiction and bullying statistics, according to 2016 Monitoring the Future survey:
- More than 17% of children have tried drugs by 8th grade
- Almost 50% have used illicit drugs by senior year in high school
- Childhood alcohol use rates are even higher
According to the CDC’s 2015 Youth Risk Behavior Survey:
- 20% of American high schoolers have been bullied in school in the past year
- More than 15% have been bullied electronically in the past year
Bullying can erode a child’s self-esteem. It can deplete their confidence, even for those who parents may believe are confident enough to endure a bully. Over time, they learn to question their self-worth. If a bully targets a specific attribute of the individual, they may begin to obsess over it.Some bullying statistics show that those who have been bullied are six times more likely to be diagnosed with mental health issues. It is extremely common for victims of bullying to develop progressive behavioral disorders such as:
Over time, they may turn to alcohol or drugs to ease the pain. Also, the desire to fit in and feel accepted can lead a child using drugs to connect with people. Several studies show the risk factors for psychological health problems, substance abuse, and bullying statistics often overlap.
Similarity in Symptoms
When we look closer at bullying statistics and at the warning signs of substance abuse, we find that the symptoms are extremely similar.
Common Symptoms of Bullying
- Changes in sleep patterns
- Changes in eating habits
- Eating disorders
- Poor performance in school or work
- Loss of interest in activities
- Alcohol or drug use
Common Symptoms of Substance Use Disorder
- Mood swings
- Poor performance in school or work
- Withdrawal from social activities
- Health problems
Looking at some of the more general warning signs we can see how many are present concerning both issues.
Substances and Bullying Statistics
Ultimately, drugs can become a crutch for numbing the emotional pain of being bullied. While it is harder to predict whether being the victim of bullying will lead to substance abuse, with bullies there is also a very real risk of developing issues with drug use and addiction.
Bullying statistics often show that bullies themselves typically suffer from a variety of emotional and behavioral challenges. Sometimes a child lives in a home with domestic violence, and so they become aggressive with their peers to expel their frustration. Yet, they may still use drugs or alcohol to escape the painful life at home. Even the act of bullying itself is typically an indication of diminished self-worth, and just like with the victims, that lack of self-worth can lead them to use drugs.
Some even believe bullying could be comparable to an addiction itself. Some psychologists compare bullying to other ‘process addictions’ like gambling, overworking or shopping. While we do not recognize bullying as an addiction, many believe the comparison could be helpful to address the issue.
Compassion and Care
Whether or not someone is a victim or bullying, or has been a bully themselves, we all deserve respect and compassion. When it comes to providing care for those who struggle with substance use disorder, it should always be a priority to help people develop healthy coping skills, while gaining self-worth. As people struggle to deal with emotional and behavioral challenges, there should be resources there to help guide them toward personal development. Not just getting off of substances, but also to empower them as an individual.
One issue we have with facing bullying head-on is that people typically think of a “bully” as someone inherently bad. However, life is not so simple. A child who bullies isn’t a bad child, they are just interacting with their world in an unhealthy and aggressive way. They still deserve understanding and support.
We commonly see the same stigma with people struggling with addiction. Too often they are labeled as “bad” people, but the truth is that they are just dealing with things in a self-destructive and unhealthy way. Dealing with substance use disorder and with bullying means meeting it with love and care, not judgment and punishment.
Perhaps if focus more on supporting people, we have a better chance of changing addiction and bullying statistics for the betterment of everyone.
Palm Healthcare Company believes in the importance of compassionate and comprehensive care for those struggling with substance abuse and addiction. Providing a safe medical detox, a personalized recovery program and an innovative approach to holistic health, our mission is to help people transform into the person they want to be. If you or someone you love is struggling, please call toll-free now.
CALL NOW 1-888-922-5398